SBIR/STTR Research Award
Development of Anti Diphtheria Toxin Therapeutic Anitbodies for Use in Humans
Award amount
$1,000,000Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Centers for Disease Control and Prevention
- Recipient company
- ANTAGEN BIOSCIENCES INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HXD6EFH2ND57
- Solicitation number
- Not reported
- Topic code
- ODCDC
Research abstract
Atagen will collaborate with MBL to consolidate resources and propose a streamlined Phase II research program as follows AIM Comparison of to C in vitro and in vivo to select lead Mab for development AIM Standardize animal model s and establish non inferiority lead Mab to standard of care equine DAT in vivo efficacy study AIM Toxicology studies with lead Mab
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- FcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines
- Development of afucosylated monoclonal antibodies with enhanced effector functions to combat malaria
- SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES
- Nanoparticle Delivery of HIV Env Trimer for Inducing Somatic Hypermutation and bNAb
- The purpose of this contract is to evaluate and modulate the molecular pathways involved in regulating and enhancing HIV envelope/antigen expression in mammalian cell lines and to accelerate development of purification platforms in a cGMP manufacturing se
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Community Based Worksite Wellness App Linking Employees to Wellness Resources Zenji
- Nitric Oxide Releasing Ultra Slippery Antibacterial Surfaces for Indewelling Catheter Applications
- Developing a Point of CarePOCLateral Flow AssayLFAto Detect Taenia Solium
- Fluorescent Qdot Immunochromatographic Test Strips for Influenza A B and Group A Strep
- Development of a Benchtop Laboratory Platform for Amplicon Deep Sequencing
Research funding history
8 SBIR/STTR records share this UEI (2011–2022). Reported award amounts total $3,699,909. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services